Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
Scale Your Vaccine Development with Path-to-PAD
The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD...
How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines
While many biopharmaceutical companies are built to fulfill a need, Resilience was built to serve innovation. Founded during the COVID-19 pandemic in...
Successful Development and Manufacturing of Vaccines Containing Aluminum Adjuvants
When added to vaccines, adjuvants such as aluminum salts can provide various benefits to drug products. Understanding the challenges associated with...
Developing New Medicines Through Artificial Intelligence
On September 30, 2012, a computer program named “AlexNet” won an international competition and ushered in a new age of artificial intelligence (AI)....
The Stage-Gate Model: A Proven Approach to Streamline Biomanufacturing
As biopharma companies outsource more specialized activity to CDMOs, successful technology transfer becomes even more integral to project success. To...
Resilience builds lab supply chain tracking platform on AWS
by Adam Mendez, Alissa Gordon, and Lee Tessler Originally published on AWS | 27 NOV 2023 We would like to acknowledge the valuable contributions of...
